Einhorn Offers Internship To Regis Philbin

May 30 2014 | 9:37am ET

There will be an 82-year-old intern stalking the halls at Greenlight Capital this summer if founder David Einhorn gets his way.

Einhorn suggested that legendary talk-show host Regis Philbin join the activist hedge fund after Philbin said last year that he was sticking with his investment in Micron Technologies—just before Greenlight began buying up a large stake in the company, which it once shorted.

“I have an idea for you,” Einhorn proffered Philbin on CNBC’s “Fast Money” this week. “You did such a good job finding Micron, and then it doubled, and I thought it was good. And then I though maybe I could take your advice for the summer, and I was wondering where trying to get some young blood in at Greenlight, some young minds, and I was wondering if you want to come intern for the summer.”

“Exactly what I’ve got,” Philbin joked. “Some young blood.”

Philbin, who retired from his morning show in 2011, did not commit to taking the job.

Micron’s success helped fuel Greenlight’s returns last year. Einhorn told CNBC that the stock still has room to grow.

“It’s a volatile stock, and very subject to going down a few dollars here or there,” he said. “But we think the business there has fundamentally changed, and we think the consensus estimates are dramatically too low. And the quality of the business is high, higher than people think, and we think there is still a lot more upside to go.”


In Depth

Israeli Hedge Fund Harnesses Big Data

Jul 28 2014 | 8:10am ET

Apica Green is a multi-million dollar Israeli hedge fund that is based in Tel Aviv...

Lifestyle

David Yarrow On Growing His Hedge Fund And Shooting The Animals And People Of Africa - As A Photographer

Jul 23 2014 | 6:44am ET

While he’s always been a photographer, recent expeditions to Iceland, Ethiopia...

Guest Contributor

Why Is The Shipping Industry Underwater?

Jul 31 2014 | 7:31am ET

Anyone who’s taken a look at the global shipping industry recently probably knows...

 

Publisher's Note